Inovio Pharmaceuticals Inc. (INO)

Inovio Pharmaceuticals Inc. (INO $2.39)
- $2.39 Cap: $127M
- View INO Profile
- View Questions on INO

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Inovio Pharmaceuticals Inc. (INO $2.39)
- $2.39 Cap: $127M
- View INO Profile
- View Questions on INO

Q: Despite all the short squeezing news on this stock. What do you guys think of INO as a biotech company, balance sheet, insider ownership, pipeline, upcoming earnings, long term outlook, risks, covid pipeline......

Thanks

Read Answer Asked by James on February 02, 2021

Regeneron Pharmaceuticals Inc. (REGN $583.24)
- $583.24 P/E (TTM): 14.73X Cap: $61.81B
- View REGN Profile
- View Questions on REGN
Pfizer Inc. (PFE $26.27)
- $26.27 P/E (TTM): 14.06X Cap: $149.35B
- View PFE Profile
- View Questions on PFE
IMV Inc. (IMV $1.12)
- $1.12 Cap: $13M
- View IMV Profile
- View Questions on IMV
Inovio Pharmaceuticals Inc. (INO $2.39)
- $2.39 Cap: $127M
- View INO Profile
- View Questions on INO
Novavax Inc. (NVAX $9.22)
- $9.22 P/E (TTM): 3.82X Cap: $1.53B
- View NVAX Profile
- View Questions on NVAX
Moderna Inc. (MRNA $27.34)
- $27.34 Cap: $10.63B
- View MRNA Profile
- View Questions on MRNA
BioNTech SE (BNTX $106.06)
- $106.06 Cap: $25.45B
- View BNTX Profile
- View Questions on BNTX

Q: Is there a Canadian company that you would recommend that possibly would benefit from a vaccine to overcome Covid 19, if not what U.S. or international company would you recommend? Thank You.

Read Answer Asked by Brian on July 14, 2020

Amgen Inc. (AMGN $295.54)
- $295.54 P/E (TTM): 24.03X Cap: $159.10B
- View AMGN Profile
- View Questions on AMGN
Johnson & Johnson (JNJ $188.89)
- $188.89 P/E (TTM): 20.12X Cap: $454.91B
- View JNJ Profile
- View Questions on JNJ
Inovio Pharmaceuticals Inc. (INO $2.39)
- $2.39 Cap: $127M
- View INO Profile
- View Questions on INO
Novavax Inc. (NVAX $9.22)
- $9.22 P/E (TTM): 3.82X Cap: $1.53B
- View NVAX Profile
- View Questions on NVAX
Repligen Corporation (RGEN $145.93)
- $145.93 Cap: $8.20B
- View RGEN Profile
- View Questions on RGEN
Moderna Inc. (MRNA $27.34)
- $27.34 Cap: $10.63B
- View MRNA Profile
- View Questions on MRNA
Adaptive Biotechnologies Corporation (ADPT $14.35)
- $14.35 Cap: $2.21B
- View ADPT Profile
- View Questions on ADPT
Sorrento Therapeutics Inc. (SRNE)
- P/E (TTM): -0.1X Cap: $141M
- View SRNE Profile
- View Questions on SRNE

Q: Hello 5i Team,
Could you please tell me the names of the companies that are developing a vaccine against Covid 19. Is there an ETF that tracks them?
Thanks,
Antoine

Read Answer Asked by Antoine on June 30, 2020